1 withdrawn. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
Follow Skyline Biosciences: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| This Study is to Evaluate the Safety and Pharmacokinetics of SBS-101 in Patients With Oral Premalignant Lesions SBS-101, Placebo - Leukoplakia, Oral | Phase 1 | Withdrawn | Skyline Biosciences | 2022-01-01 | 2021-10-19 |
Erythroplasia (1) · Leukoplakia, Oral (1)
United States (1)
Joy Schleyer (1)